These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 29629912)
1. Technical Pitfall in 68Ga-Prostate Specific Membrane Antigen Imaging: Altered Biodistribution Caused by Free 68Ga-Citrate Due to Radiolysis Showing Increased Vascular Activity. Hod N; Anconina R; Levin D; Ezroh Kazap D; Lantsberg S Clin Nucl Med; 2018 Jun; 43(6):e203-e205. PubMed ID: 29629912 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Compressed Central Zone Uptake on PSMA PET/CT-A Potential Pitfall in Interpretation. Ganeshalingam R; Hsiao E Clin Nucl Med; 2019 Jul; 44(7):570-571. PubMed ID: 31107744 [TBL] [Abstract][Full Text] [Related]
4. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging. Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090 [TBL] [Abstract][Full Text] [Related]
6. Uptake in sympathetic ganglia on Kanthan GL; Hsiao E; Vu D; Schembri GP J Med Imaging Radiat Oncol; 2017 Dec; 61(6):732-738. PubMed ID: 28623872 [TBL] [Abstract][Full Text] [Related]
7. de Jong AC; Smits M; van Riet J; Fütterer JJ; Brabander T; Hamberg P; van Oort IM; de Wit R; Lolkema MP; Mehra N; Segbers M; van der Veldt AAM J Nucl Med; 2020 Nov; 61(11):1607-1614. PubMed ID: 32169916 [TBL] [Abstract][Full Text] [Related]
9. A potential pitfall in the use of Elri T; Aras M; Salihoglu YS; Erdemir RU; Cabuk M Rev Esp Med Nucl Imagen Mol; 2017; 36(1):65-66. PubMed ID: 27666999 [No Abstract] [Full Text] [Related]
10. García Garzón JR; de Arcocha Torres M; Delgado-Bolton R; Ceci F; Alvarez Ruiz S; Orcajo Rincón J; Caresia Aróztegui AP; García Velloso MJ; García Vicente AM; Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):130-138. PubMed ID: 28941866 [TBL] [Abstract][Full Text] [Related]
11. The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature. Eissa A; Elsherbiny A; Coelho RF; Rassweiler J; Davis JW; Porpiglia F; Patel VR; Prandini N; Micali S; Sighinolfi MC; Puliatti S; Rocco B; Bianchi G Minerva Urol Nefrol; 2018 Oct; 70(5):462-478. PubMed ID: 29664244 [TBL] [Abstract][Full Text] [Related]
12. PET/CT With Giovacchini G; Giovannini E; Riondato M; Ciarmiello A Curr Radiopharm; 2018; 11(1):4-13. PubMed ID: 29090673 [TBL] [Abstract][Full Text] [Related]
13. Frusemide aids diagnostic interpretation of Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852 [TBL] [Abstract][Full Text] [Related]
14. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer. Dietlein M; Kobe C; Kuhnert G; Stockter S; Fischer T; Schomäcker K; Schmidt M; Dietlein F; Zlatopolskiy BD; Krapf P; Richarz R; Neubauer S; Drzezga A; Neumaier B Mol Imaging Biol; 2015 Aug; 17(4):575-84. PubMed ID: 26013479 [TBL] [Abstract][Full Text] [Related]